Company Revenue

The company grew more than 20% in the first quarter of 2025 as it seeks to cement itself as the...

The company maintained its exceptional pace of orthopedic growth during the first quarter of 2025 driven by execution and robotic...

The company grew in the low single digits in the first quarter of 2025 as it incrementally improves its performance....

The company's orthopedic sales grew in the low single digits in the first quarter as it attempts to improve its...

One-time events and competitive pressures created a slower start to 2025 for J&J MedTech's orthopedic sales....

The company grew in the high single digits in 2024 as it made significant progress integrating its Lima acquisition....

The company grew nearly 27% in 2024 as its technology and procedural approach continued to compel surgeon adoption in the...

The company grew in the high single digits in 2024 and made moves to prioritize its most profitable growth opportunities...

The company's 12-Point Plan is producing results, but China will remain a major drag on sales and profitability in 2025....

The company grew in the mid-single-digits in the fourth quarter of 2024 and set records for its enabling technology sales...